Globoid Cell Leukodystrophy (Krabbe Disease) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 33 pages | ID: GBDBF5008E7EN
VPAResearch

Abstracts

Globoid Cell Leukodystrophy (Krabbe Disease) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Globoid Cell Leukodystrophy (Krabbe Disease) disease clinical trials. The research work analyzes the ongoing Globoid Cell Leukodystrophy (Krabbe Disease) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Globoid Cell Leukodystrophy (Krabbe Disease) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Globoid Cell Leukodystrophy (Krabbe Disease) clinical trials.

Scope of the Report-

• Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Globoid Cell Leukodystrophy (Krabbe Disease)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Globoid Cell Leukodystrophy (Krabbe Disease) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Globoid Cell Leukodystrophy (Krabbe Disease) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials by Phase
3.2 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials by Type
3.3 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials
4.2 Top 10 Countries conducting Globoid Cell Leukodystrophy (Krabbe Disease) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials by Sponsor Type
5.2 Globoid Cell Leukodystrophy (Krabbe Disease) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Globoid Cell Leukodystrophy (Krabbe Disease) Trials by year
6.2 Subjects Recruited for Globoid Cell Leukodystrophy (Krabbe Disease) Trials by Phase
6.3 Subjects Recruited for Globoid Cell Leukodystrophy (Krabbe Disease) Trials by Trial Type
6.4 Subjects Recruited for Globoid Cell Leukodystrophy (Krabbe Disease) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials- Phase
7.2 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials- Phase
7.3 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials- Phase
7.4 Ongoing Globoid Cell Leukodystrophy (Krabbe Disease) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Country
Figure 2: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Phase of Development, 2018
Figure 3: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Status, 2018
Figure 4: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Type, 2018
Figure 5: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials Split by Region, 2000-2018
Figure 6: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Type of Economy, 2018
Figure 7: Globoid Cell Leukodystrophy (Krabbe Disease)- Enrolment by Phase, 2018
Figure 8: Globoid Cell Leukodystrophy (Krabbe Disease)- Enrolment by Trial Type, 2018
Figure 9: Globoid Cell Leukodystrophy (Krabbe Disease)- Enrolment by Recruitment Status, 2018
Figure 10: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Sponsor Type, 2018
Figure 11: Globoid Cell Leukodystrophy (Krabbe Disease)- Enrolment by Type of Sponsors
Figure 12: Globoid Cell Leukodystrophy (Krabbe Disease)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Sponsor Type, 2018
Table 2: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Economy Type, 2018
Table 3: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials by Region, 2018
Table 4: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Globoid Cell Leukodystrophy (Krabbe Disease)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Globoid Cell Leukodystrophy (Krabbe Disease)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Globoid Cell Leukodystrophy (Krabbe Disease)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Globoid Cell Leukodystrophy (Krabbe Disease)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Globoid Cell Leukodystrophy (Krabbe Disease)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company